middle.news
How Biome Australia’s Record Sales and New Products Could Transform FY26
8:51am on Tuesday 29th of July, 2025 AEST
•
Healthcare
Read Story
How Biome Australia’s Record Sales and New Products Could Transform FY26
8:51am on Tuesday 29th of July, 2025 AEST
Key Points
Q4 sales revenue reached $5.04 million, up 33% year-on-year
Positive EBITDA of $78k in Q4, with FY25 EBITDA expected to exceed $900k
Annual sales revenue surged 41% to $18.4 million
Launched Activated Therapeutics range and secured international distribution deals
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Biome Australia (ASX:BIO)
OPEN ARTICLE